Lycia Therapeutics stock surges in IPO debut after pricing about $317.5M offering
发生了什么
The drug developer priced 17.64 million shares at $18 each, and the offering is expected to close on Oct. 26
摘要按规则整理自下方来源原文
The drug developer priced 17.64 million shares at $18 each, and the offering is expected to close on Oct. 26
摘要按规则整理自下方来源原文